Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by JOHNSON DAVID LEE. Insider active across 2 companies, notably Global Blood Therapeutics, Inc.. Aggregated, 16 disclosures have been recorded. Activity tracked since 31 August 2021. The latest transaction was filed on 18 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations16 total
26,900 shares0Class A Common StockSEC:0001415889-25-004844:0
22,000 shares0Common StockSEC:0000899243-22-033150:0
365 shares@ US$25.3723.2% of flowCommon StockSEC:0000899243-22-030479:0
6,770 sharesCommon StockSEC:0000899243-22-027635:0
4,375 sharesCommon StockSEC:0000899243-22-013880:0
472 shares@ US$25.3735.1% of flowCommon StockSEC:0000899243-22-009262:0
6,770 sharesCommon StockSEC:0000899243-22-004634:0
6,770 sharesCommon StockSEC:0000899243-22-004634
4,375 sharesCommon StockSEC:0000899243-21-039183:0
4,375 sharesCommon StockSEC:0000899243-21-039183
6,770 sharesCommon StockSEC:0000899243-21-037667:0
6,770 sharesCommon StockSEC:0000899243-21-037667
480 shares@ US$24.3932.5% of flowCommon StockSEC:0000899243-21-035223:0
480 shares@ US$24.3924.9% of flowCommon StockSEC:0000899243-21-035223
6,770 sharesCommon StockSEC:0000899243-21-031344
6,770 sharesCommon StockSEC:0000899243-21-031344:0
About JOHNSON DAVID LEE
David Lee Johnson is a director at Global Blood Therapeutics, Inc.